Histogenics Corp. Company Profile (NASDAQ:HSGX)

About Histogenics Corp.

Histogenics Corp. logoHistogenics Corporation is a regenerative medicine company. The Company is focused on developing and commercializing products in the musculoskeletal segment of the marketplace. The Company's product candidate, NeoCart utilizes various aspects of regenerative medicine platform to develop a tissue implant intended to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. NeoCart is a cartilage-like implant created using a patient's own cartilage cells through a series of tissue engineering processes. The patient's cells are separated from a tissue biopsy specimen extracted from the patient and multiplied in its laboratory. The cells are then infused into its scaffold that provides structure for the developing implant. Before NeoCart is implanted in a patient, the cell- and scaffold construct undergoes a bioengineering process in the Company's Tissue Engineering Processor (TEP). The Company has operations in the United States and Israel.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: HSGX
  • CUSIP:
Key Metrics:
  • Previous Close: $2.97
  • 50 Day Moving Average: $2.27
  • 200 Day Moving Average: $2.21
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.26
  • P/E Growth: 0.00
  • Market Cap: $39.41M
  • Outstanding Shares: 13,271,000
  • Beta: 1.77
Additional Links:
Companies Related to Histogenics Corp.:

Analyst Ratings

Consensus Ratings for Histogenics Corp. (NASDAQ:HSGX) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $9.75 (228.28% upside)

Analysts' Ratings History for Histogenics Corp. (NASDAQ:HSGX)
Show:
DateFirmActionRatingPrice TargetDetails
8/11/2016BTIG ResearchUpgradeNeutral -> Buy$3.50View Rating Details
5/12/2016Canaccord GenuityReiterated RatingBuyView Rating Details
11/13/2015Cowen and CompanyLower Price TargetOutperform$17.00 -> $12.50View Rating Details
11/13/2015Needham & Company LLCLower Price TargetBuy$17.00 -> $15.00View Rating Details
(Data available from 8/29/2014 forward)

Earnings

Earnings History for Histogenics Corp. (NASDAQ:HSGX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/11/2016Q216($0.60)($0.61)ViewListenView Earnings Details
5/12/2016Q116($0.59)($0.60)ViewListenView Earnings Details
3/10/2016Q415($0.59)($0.63)ViewListenView Earnings Details
11/12/2015Q315($0.47)($0.61)ViewListenView Earnings Details
8/12/2015Q215($0.49)($0.58)ViewListenView Earnings Details
5/14/2015Q115($1.34)($0.60)ViewListenView Earnings Details
2/26/2015Q414$0.66$1.70ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Histogenics Corp. (NASDAQ:HSGX)
Current Year EPS Consensus Estimate: $-2.42 EPS
Next Year EPS Consensus Estimate: $-2.36 EPS

Dividends

Dividend History for Histogenics Corp. (NASDAQ:HSGX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Histogenics Corp. (NASDAQ:HSGX)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Histogenics Corp. (NASDAQ:HSGX)
DateHeadline
live-pr.com logoNewly released market study: Histogenics Corporation (HSGX) - Financial and Strategic SWOT Analysis Review (NASDAQ:HSGX)
www.live-pr.com - August 22 at 10:05 AM
News IconHistogenics Corp (NASDAQ:HSGX) A Momentum Pick As It Races Through Pivotal Enrollment (NASDAQ:HSGX)
streetregister.com - August 19 at 8:26 AM
seekingalpha.com logoHistogenics' (HSGX) CEO Adam Gridley on Q2 2016 Results - Earnings Call Transcript (NASDAQ:HSGX)
seekingalpha.com - August 12 at 5:34 PM
streetinsider.com logoBTIG Upgrades Histogenics Corp. (HSGX) to Buy (NASDAQ:HSGX)
www.streetinsider.com - August 12 at 5:34 PM
finance.yahoo.com logoBTIG Upgrades Histogenics To Buy, Sets $3.50 Price Target (NASDAQ:HSGX)
finance.yahoo.com - August 12 at 5:34 PM
finance.yahoo.com logoEdited Transcript of HSGX earnings conference call or presentation 11-Aug-16 12:30pm GMT (NASDAQ:HSGX)
finance.yahoo.com - August 12 at 8:37 AM
biz.yahoo.com logoQ2 2016 Histogenics Corp Earnings Release - Before Market Open (NASDAQ:HSGX)
biz.yahoo.com - August 11 at 5:43 PM
finance.yahoo.com logoHistogenics reports 2Q loss (NASDAQ:HSGX)
finance.yahoo.com - August 11 at 8:30 AM
nasdaq.com logoHistogenics Corporation Announces Second Quarter 2016 Financial and Operating Results (NASDAQ:HSGX)
www.nasdaq.com - August 11 at 8:30 AM
finance.yahoo.com logoHistogenics Corporation to Announce Second Quarter 2016 Financial Results on August 11, 2016 (NASDAQ:HSGX)
finance.yahoo.com - July 28 at 8:30 AM
finance.yahoo.com logoHistogenics Corporation to Present at the Canaccord Genuity Growth Conference (NASDAQ:HSGX)
finance.yahoo.com - July 27 at 8:30 AM
biz.yahoo.com logoHISTOGENICS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:HSGX)
biz.yahoo.com - June 22 at 5:02 PM
fxpips.com logoManufacturing Stocks Daily Report (NASDAQ:HSGX)
www.fxpips.com - June 17 at 8:15 AM
investornewswire.com logoHistogenics Corporation (NASDAQ:HSGX) Impact Score At 0 - Investor Newswire (NASDAQ:HSGX)
www.investornewswire.com - May 28 at 1:18 PM
biz.yahoo.com logoQ1 2016 Histogenics Corp Earnings Release - Before Market Open (NASDAQ:HSGX)
biz.yahoo.com - May 12 at 7:07 AM
feeds.reuters.com logoBRIEF-Histogenics Corp Q1 loss per share $0.60 (NASDAQ:HSGX)
feeds.reuters.com - May 12 at 6:52 AM
sg.finance.yahoo.com logoHistogenics reports 1Q loss (NASDAQ:HSGX)
sg.finance.yahoo.com - May 12 at 6:41 AM
finance.yahoo.com logoHistogenics Corporation Announces First Quarter 2016 Financial and Operating Results (NASDAQ:HSGX)
finance.yahoo.com - May 12 at 6:30 AM
biz.yahoo.com logoHISTOGENICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:HSGX)
biz.yahoo.com - May 10 at 9:16 AM
finance.yahoo.com logoHistogenics Corporation Acquires NeoCart® Development and Commercialization Rights for Japanese Market (NASDAQ:HSGX)
finance.yahoo.com - May 10 at 9:00 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Histogencis Corporation -- HSGX (NASDAQ:HSGX)
finance.yahoo.com - May 4 at 5:32 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Histogenics Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors (NASDAQ:HSGX)
finance.yahoo.com - May 4 at 11:20 AM
finance.yahoo.com logoHistogenics Corporation to Announce First Quarter 2016 Financial Results on May 12, 2016 (NASDAQ:HSGX)
finance.yahoo.com - April 28 at 8:30 AM
finance.yahoo.com logoHistogenics Corporation To Present At Needham & Company’s 15th Annual Healthcare Conference (NASDAQ:HSGX)
finance.yahoo.com - March 31 at 8:30 AM
finance.yahoo.com logoEdited Transcript of HSGX earnings conference call or presentation 10-Mar-16 1:30pm GMT (NASDAQ:HSGX)
finance.yahoo.com - March 14 at 12:31 PM
News IconHistogenics Corporation (NASDAQ:HSGX) Short Interest Decreased By 3.73% - Franklin Independent (NASDAQ:HSGX)
www.franklinindependent.com - February 26 at 1:55 PM
News IconChanges To Broker Targets On Histogenics Corporation (HSGX) - Share Trading News (NASDAQ:HSGX)
www.sharetrading.news - February 26 at 1:55 PM
finance.yahoo.com logoHistogenics Corporation to Present at Upcoming Investor Conferences (NASDAQ:HSGX)
finance.yahoo.com - February 25 at 8:30 AM
biz.yahoo.com logoHISTOGENICS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:HSGX)
biz.yahoo.com - February 2 at 4:18 PM
finance.yahoo.com logo4:13 pm Histogenics updates on its ongoing NeoCart Phase 3 clinical trial; 50% of patients enrolled - expect to complete enrollment by the end of Q2 2017 (NASDAQ:HSGX)
finance.yahoo.com - February 2 at 4:13 PM
finance.yahoo.com logoHistogenics Corporation Provides NeoCart® Phase 3 Clinical Trial Enrollment Update (NASDAQ:HSGX)
finance.yahoo.com - February 2 at 4:05 PM
finance.yahoo.com logoHistogenics Corporation to Present at 18th Annual BIO CEO & Investor Conference (NASDAQ:HSGX)
finance.yahoo.com - January 26 at 8:30 AM
nasdaq.com logoHistogenics Corporation to Present at Biotech Showcase 2016 (NASDAQ:HSGX)
www.nasdaq.com - January 6 at 9:01 AM
finance.yahoo.com logoHistogenics Corporation to Present at Biotech Showcase 2016 (NASDAQ:HSGX)
finance.yahoo.com - January 6 at 8:30 AM
biz.yahoo.com logoHISTOGENICS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:HSGX)
biz.yahoo.com - December 21 at 8:31 AM
finance.yahoo.com logoHistogenics Corporation Announces Amendment to NeoCart® Phase 3 Clinical Trial Enrollment Criteria (NASDAQ:HSGX)
finance.yahoo.com - December 21 at 8:15 AM
finance.yahoo.com logoHISTOGENICS CORP Financials (NASDAQ:HSGX)
finance.yahoo.com - December 8 at 1:18 PM
finance.yahoo.com logoEdited Transcript of HSGX earnings conference call or presentation 12-Nov-15 1:30pm GMT (NASDAQ:HSGX)
finance.yahoo.com - November 13 at 9:58 AM
biz.yahoo.com logoHistogenics Corp Earnings Call scheduled for 8:30 am ET today (NASDAQ:HSGX)
biz.yahoo.com - November 12 at 8:30 AM
sg.finance.yahoo.com logoHistogenics reports 3Q loss (NASDAQ:HSGX)
sg.finance.yahoo.com - November 12 at 7:41 AM
biz.yahoo.com logoQ3 2015 Histogenics Corp Earnings Release - Before Market Open (NASDAQ:HSGX)
biz.yahoo.com - November 12 at 7:07 AM
biz.yahoo.com logoHISTOGENICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:HSGX)
biz.yahoo.com - November 12 at 6:46 AM
finance.yahoo.com logoHistogenics Corporation Announces Third Quarter 2015 Financial and Operating Results (NASDAQ:HSGX)
finance.yahoo.com - November 12 at 6:30 AM
finance.yahoo.com logoHistogenics Corporation to Announce Third Quarter 2015 Financial Results on November 12, 2015 (NASDAQ:HSGX)
finance.yahoo.com - October 29 at 8:30 AM
noodls.com logoHistogenics Corporation to Participate in Upcoming Scientific and Investor Conferences (NASDAQ:HSGX)
www.noodls.com - October 1 at 10:58 AM
finance.yahoo.com logoEdited Transcript of HSGX earnings conference call or presentation 12-Aug-15 12:30pm GMT (NASDAQ:HSGX)
finance.yahoo.com - August 14 at 2:54 PM

Social

Histogenics Corp. (NASDAQ:HSGX) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff